Jack Dreyfus and The Story of a Remarkable Medicine.
This web site is dedicated to the life and work of Jack Dreyfus, founder of Dreyfus & Co, the Dreyfus Fund, and the Dreyfus Health Foundation, set up to researching the benefits of a drug called Dilantin (phenytoin).
Jack Dreyfus died peacefully on March 27, 2009 at the age of 95. For more details in the coming days and weeks, please visit the "News" section of this website.
This site includes over 500 new studies and references detailing recent clinical work on new symptoms and disorders for which PHT has proven useful. These include: Obsessive-Compulsive Disorder, Motion Sickness, ADHD, Tourette's Syndrome, and many other conditions. For a list
of these references, click here.
In January 2006, new basic mechanisms information was added on magnesium, peptides, neurosteroids, cerebral metabolism, spinal cord, physiological models of stress, cardiac muscle, and others. Please visit the Basic Mechanisms section for more on these and other subjects.
For forty years, Jack Dreyfus has dedicated himself to disseminating information to the public about phenytoin, which has been found useful for over eighty symptoms and disorders, and is currently being used for a wide variety of conditions in nearly thirty countries around the world. However, because of a flaw in the way the government brings medicines to the attention of the public, the drug is still listed for only one use in the United States.
In his most recent book, Written in Frustration, Jack Dreyfus examines the obstacles to bringing phenytoin to the attention of doctors and the American public and brings his brilliant sense of probabilities to the issue of how likely it is that a drug can be useful for so many conditions. In a time of ever-increasing health care costs, questions about drug safety, and concern with government accountability and transparency, the message of Written in Frustration has never been more urgent or necessary
Those who are interested in Written in Frustration, will also be interested in The Story of a Remarkable Medicine. This book details the Jack Dreyfus’s extraordinary life and how his experience of depression led him to discover phenytoin and dedicate the rest of his life to helping people all over the world.
The site is split into three different parts. In "Life" you can explore the remarkable life and skills of Jack Dreyfus: his successes on Wall Street, his genius at gin rummy and bridge, his achievements in the sports of horseracing, golf, and tennis—all told with his customary dry wit and charm.
In "Medicine" you can read how Jack dealt with the severe depression that affected him in the late 1950s. After seeing a physician six days a week, for over five years, Jack had the incredible luck to think that the depression was caused by inappropriate electrical activity in his body. He asked his physician to allow him to try the drug, Dilantin, that was used for epilepsy. To the surprise of both Jack Dreyfus and the doctor, he returned to good health, promptly. This section looks at Jack's efforts to bring this remarkable drug to the attention of doctors and the United States government.
Finally, in "Clinical
Studies," you can read some of the thousands of studies in over 350 medical journals that have shown the usefulness of phenytoin for a wide range of ailments. This section has been updated with over eighty new studies from the 1990s and 2000s, showing that Dilantin is useful for even more conditions than previously thought. Feel free to take the information on this site, or the books, to your doctor.
At any point, you can search for any word or phrase on this site using the search engine.
The medical and scientific materials contained in this website are provided on an “as is” basis. Neither Jack Dreyfus nor the Dreyfus Charitable Foundation nor any other party including the online provider and maintainers of the site makes any guarantees or warranties of any kind, either express or implied, including but not limited to, implied warranties of merchantability or fitness for a particular purpose, warranties as to the accuracy, completeness, currentness or results to be obtained from accessing and using the material contained in this website, nor any material which can be accessed (via direct or indirect hyperlink or otherwise) through this website.
For more information, please read Advisory